Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of British Columbia

$294,525.00

The critical role of plasma cholesterol in the pathogenesis of muscular dystrophy

FY 2017-18

Summary
Muscular dystrophy is caused by mutations in key genes responsible for myofiber homeostasis. However, we have found the same genes expressed in the blood vessels that perfuse skeletal muscles, raising the hypothesis that deficient muscles in muscular dystrophy are perfused by deficient blood vessels, and that one can aggravate another. To test the interplay between blood vessels and muscular dystrophy, we took mice with muscular dystrophy and gave them a common blood vessel disease called atherosclerosis by altering their plasma lipid profile, what most people refer to as high cholesterol. To our surprise, these mice show drastically aggravated muscular dystrophy, up to the point of completely incapable of any locomotion mid-age, something never reported in mouse models of muscular dystrophy. Since it would be relatively easy to lower cholesterol in patients suffering from muscular dystrophy in an attempt to attenuate the inevitable rate of muscle function loss, we propose to shed a new light on plasma lipids and associated lipoproteins in muscle disease and show that improving lipid profiles attenuates muscular dystrophy in what we believe to be the most advanced pre-clinical model of MD.
Program
Project Grant
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
371347
Name
Bernatchez Pascal N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Movement & Exercise
Projecttitle
The critical role of plasma cholesterol in the pathogenesis of muscular dystrophy
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$294,525
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cholesterol; Duchenne Muscular Dystrophy; Limb-Girdle Muscular Dystrophy; Lipoproteins
Abstract
Muscular dystrophy is caused by mutations in key genes responsible for myofiber homeostasis. However, we have found the same genes expressed in the blood vessels that perfuse skeletal muscles, raising the hypothesis that deficient muscles in muscular dystrophy are perfused by deficient blood vessels, and that one can aggravate another. To test the interplay between blood vessels and muscular dystrophy, we took mice with muscular dystrophy and gave them a common blood vessel disease called atherosclerosis by altering their plasma lipid profile, what most people refer to as high cholesterol. To our surprise, these mice show drastically aggravated muscular dystrophy, up to the point of completely incapable of any locomotion mid-age, something never reported in mouse models of muscular dystrophy. Since it would be relatively easy to lower cholesterol in patients suffering from muscular dystrophy in an attempt to attenuate the inevitable rate of muscle function loss, we propose to shed a new light on plasma lipids and associated lipoproteins in muscle disease and show that improving lipid profiles attenuates muscular dystrophy in what we believe to be the most advanced pre-clinical model of MD.
Competitiondate
201709
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bernatchez, Pascal N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $294,525~ $0~